Eric H. Bjerkholt
2011 - Sunesis Pharmaceuticals
In 2011, Eric H. Bjerkholt earned a total compensation of $1.1M as Executive Vice President, Corporate Development and Finance, Chief Financial Officer and Corporate Secretary at Sunesis Pharmaceuticals, a 126% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $120,750 |
|---|---|
| Option Awards | $654,210 |
| Salary | $350,000 |
| Other | $3,466 |
| Total | $1,128,426 |
Bjerkholt received $654.2K in option awards, accounting for 58% of the total pay in 2011.
Bjerkholt also received $120.8K in non-equity incentive plan, $350K in salary and $3.5K in other compensation.
Rankings
In 2011, Eric H. Bjerkholt's compensation ranked 5,215th out of 10,747 executives tracked by ExecPay. In other words, Bjerkholt earned more than 51.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,215 out of 10,747 | 52nd |
Division Manufacturing | 1,890 out of 3,960 | 52nd |
Major group Chemicals And Allied Products | 406 out of 1,033 | 61st |
Industry group Drugs | 253 out of 781 | 68th |
Industry Pharmaceutical Preparations | 199 out of 571 | 65th |
Source: SEC filing on April 25, 2013.
Bjerkholt's colleagues
We found two more compensation records of executives who worked with Eric H. Bjerkholt at Sunesis Pharmaceuticals in 2011.